Premium breast screening programme

Premium breast screening programme is designed for women who wish to have a comprehensive assessment of the condition of their breasts and reproductive system. The programme comprises consultations with a breast specialist and an obstetrician-gynaecologist, hormonal tests and a detailed ultrasound scan of the breasts and pelvic organs.

The programme is coordinated by breast surgeon prof. habil. dr. Valerijus Ostapenko and comprises:

Consultations:

• Initial consultation with a breast specialist;
• Follow-up consultation to discuss test results and recommendations;
• Initial consultation with an obstetrician-gynaecologist.

Laboratory tests:

• Estradiol – the main female sex hormone, which influences changes in breast tissue;
• Progesterone – important for hormonal balance and regulation of the menstrual cycle;
• Prolactin – elevated levels may be associated with breast tenderness or nipple discharge;
• FSH (follicle-stimulating hormone) – helps to assess ovarian function and hormonal changes;
• LH (luteinising hormone) – plays a role in the functioning of the reproductive system and hormone regulation;
• TSH (thyroid-stimulating hormone) – the main indicator of thyroid function, which may influence breast condition and hormonal balance;
• T3 (triiodothyronine) – one of the main thyroid hormones, involved in regulating metabolism. Thyroid dysfunction may be associated with breast tenderness, changes in hormonal balance and changes in general well-being;
• T4 (thyroxine) – the main hormone produced by the thyroid, essential for normal hormonal balance and bodily functions. Changes in its levels may affect the functioning of the reproductive system and the sensitivity of breast tissue;
• Cortisol – the main stress hormone, involved in the body’s response to stress and in hormone regulation. Prolonged elevated cortisol levels may affect hormonal balance, breast sensitivity and a woman’s overall sense of well-being.

Examinations:

• Breast examination;
• Ultrasound scan of the breasts and regional lymph nodes;
• Ultrasound examination of supraclavicular and subclavian lymph nodes.

Additional diagnostic tests:

• Transvaginal ultrasound (TVE).

Individual care plan:

• A personalized 6–12-month health monitoring plan.